Preliminary results from the clinical trial of a protein drug show that the number of COVID-19 patients in need of intensive care treatment can be significantly reduced. The drug is
Tag "Synairgen"
Advertisement
Advertisement
Advertisement
Advertisement
Top Stories
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Life and Living
Advertisement
Advertisement